ABCG2 transports sulfated conjugates of steroids and xenobiotics.
about
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesIntegration of preclinical and clinical data with pharmacokinetic modeling and simulation to evaluate fexofenadine as a probe for hepatobiliary transport function.Neurosteroid transport by the organic solute transporter OSTα-OSTβ.Synthesis and structure-activity relationship studies of O-biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors.Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).ATP-binding cassette transporter G2 activity in the bovine spermatozoa is modulated along the epididymal duct and at ejaculation.Role of breast cancer resistance protein in the adaptive response to cholestasis.HIF-2α suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells.Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.Application of human placental villous tissue explants to study ABC transporter mediated efflux of 2,4-dinitrophenyl-S-glutathioneABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter.The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2).Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones.Role of the breast cancer resistance protein (ABCG2) in drug transport.Vesicle-Mediated Steroid Hormone Secretion in Drosophila melanogaster.Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates.Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers.Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents.MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells.Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion.ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.Natural polyphenols in cancer therapy.Human ABCG2: structure, function, and its role in multidrug resistance.Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions.Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?Pterostilbene: Biomedical applications.Hormonal regulation of hepatic drug biotransformation and transport systems.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
P2860
Q28067499-C4F09739-3C52-4C1A-AFDE-C6E75D64CA9BQ33460512-4C12B48D-6C62-46B8-9391-D48A2DA4F00EQ33637849-F3E218BE-7007-446B-838B-5BC6295A6325Q33773079-49692173-2BDA-41B8-A3FA-2AFB4933F681Q34176588-CBA172BA-EE27-4FD1-920A-DF40545049ADQ34207215-06291F5D-A9B9-4FB3-ACC4-A9BCEAF40217Q34211113-83D046A5-5EBE-4933-8DB7-68F3D84D909FQ34280670-8562E641-E366-4C6A-A627-E0412687FA09Q34472249-77D7B26F-FE82-4068-AA19-54399005ADAAQ34915288-DB5A7FD9-935B-407D-92DF-DA471189BAAEQ35171274-A0B4DAA3-2CEC-4707-B6AE-C07E01693FABQ35585361-88784FA8-1FC3-4CDF-82B7-424640B29730Q35655939-3BDD01EC-4673-4A8A-9033-BDEFD979DDE7Q36052743-41E72D61-B273-47CF-ABCF-2759C449853EQ36150190-15DA55A6-592C-4549-9C22-066088120CDFQ36250753-52368B68-4CEA-4578-B122-B3C2F719F7B3Q36258990-31A8AA5B-F509-43E7-AAC3-8E173E3D3188Q36349672-95B0BD43-A78F-4D39-838C-5AFCEB97276CQ36544962-8A698A98-A6D4-484C-BD68-154819058C7EQ37062623-3B4F4A35-A6FF-48C9-BABB-CF25F25EF4ABQ37132937-B9D4DDEF-77B7-4331-B2B9-2216F4816531Q37285224-CE80281C-3731-4E31-A88F-60CFB1A907B2Q37351504-B9DF7387-F7B6-42A8-BF66-E95DE8DD436BQ37464187-C7F88822-5140-4A87-9E69-E1B1D2AC15BDQ37554392-D9AFA978-FB78-4E0A-90DA-50805A83EDEAQ37595188-1FF6FD6D-2FB3-4A1E-9D49-E2ED20E2AE52Q37958162-D1E554BB-3DCA-420F-A674-A4EB6B401B94Q37964733-379D231E-2627-43A6-9E77-56C501560DA1Q38003156-2DC989A6-D221-4348-85B1-9B049D690430Q38051447-C8121EF8-F14A-4626-9047-5520F38305D7Q38055067-0F5F22BA-BC9B-4D8A-9EFF-3F604C612181Q38117659-8CDBDACF-A2D6-47C5-9674-C874A22FDC4AQ38165145-029E1680-9852-4583-A11B-8D09D80D9716Q38183877-314C0D2B-A623-4206-ADD1-CD5605BB9FA3Q38187646-F8EE6850-24FF-4726-944C-618B6F98D907Q38207943-48370C59-3AD3-40CD-BB53-B6AAE0C71586Q38514267-6C7686E2-A8D5-40D6-A8CB-4F082CF04CB3Q38704919-89B4336C-07C3-4776-B368-3A2F6F32BC03Q38958745-AF43A0AA-39B9-4436-8B1E-D5C8CAAF4EDBQ39015818-237532B9-86E8-4D02-9C11-A8ACBC6AE663
P2860
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
@en
type
label
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
@en
prefLabel
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
@en
P2093
P356
P1476
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
@en
P2093
Hiroshi Suzuki
Michiko Suzuki
Yoshikazu Sugimoto
Yuichi Sugiyama
P304
22644-22649
P356
10.1074/JBC.M212399200
P407
P577
2003-04-07T00:00:00Z